基本信息
浏览量:451
职业迁徙
个人简介
Dr. Goldberg’s research interests include focus on GI cancer and include new drug development through design and management of clinical trials, understanding inherited cancer susceptibility, discovery of markers in tumors that predict outcomes and drug sensitivity or resistance, and pooling data from patients enrolled across multiple clinical trials to extract as much value as possible from the outcome of each person who enrolled. His career has spanned three decades and he has been an author on over 300 peer reviewed publications with coauthors that range from students to internationally known researchers from around the globe. His research illustrates the value of collaboration. The major emphasis is on the biology and treatment of colorectal cancer. His most impactful work was a study funded by the NCI through a program now known as the National Clinical Trials Network. That study led to the licensing in the U.S. of the drug oxaliplatin for the indication of initial treatment of patients with metastatic colorectal cancer and the adoption of a treatment program known as FOLFOX that includes folinic acid, 5-fluoruracil and oxaliplatin.
研究兴趣
论文共 849 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 1 (2024)
Claire Gallois,Qian Shi,Levi D. Pederson,Thierry André,Timothy J. Iveson,Alberto F. Sobrero,Steven Alberts,Aimery de Gramont, Jeffrey A. Meyerhardt,Thomas George, Hans-Joachim E. Schmoll,Ioannis Souglakos,
Journal of Clinical Oncology (2024)
crossref(2023)
Annals of Oncology (2023): S56-S56
引用0浏览0引用
0
0
Cancer Researchno. 5 (2023): P4-08
Cancer control : journal of the Moffitt Cancer Center (2023): 10732748231185047
引用0浏览0WOS引用
0
0
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 14 (2023): 2621-2630
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn